Synergic effect of curcumin or lycopene with irradiation upon oral squamous cell carcinoma cells

Oral Diseases

Volumn 19, Issue 5, 2013, Pages 465-472

  Camacho Alonso, F ^a   Lopez Jornet P ^a   Tudela Mulero, M R ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Curcumin; In vitro cell line; Irradiation; Lycopene; Squamous cell carcinoma

Indexed keywords

CURCUMIN; LYCOPENE; ANTINEOPLASTIC AGENT; CAROTENOID;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; MOUTH NEOPLASMS; MULTIMODALITY CANCER THERAPY; RADIATION RESPONSE; TIME; TUMOR CELL CULTURE;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CAROTENOIDS; CELL SURVIVAL; COMBINED MODALITY THERAPY; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG SYNERGISM; HUMANS; MOUTH NEOPLASMS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 84883775426     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12025     Document Type: Article

References (61)

1. Agarwal S, Rao AV (2000). Tomato lycopene and its roles in human health and chronic diseases. CMAJ 163: 739-744
2. Aggarwal BB, Shishodia S (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421
3. Aggarwal BB, Kumar A, Bharti AC (2003). Anticancer potential of curcumin preclinical and clinical studies. Anticancer Res 23: 363-398
4. Aggarwal BB, Takada Y, Oommen OV (2004a). From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs 13: 1327-1338
5. Aggarwal S, Takada Y, Singh S, Myers JN, Aggrawal BB (2004b). Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signalling. Int J Cancer 111: 679-692
6. Ammon HPT, Anazodo MI, Safayhi H, Dhawan BN, Srimal RC (1992). Curcumin: a potent inhibitor of Leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Med 58:.226
7. Bahar G, Feinmesser R, Shpitzer T, Popovter A, Nagler RM (2007). Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 109: 54-59
8. Baselga J, Averbuch SD (2000). ZD1839 ('Iressa') as an anticancer agent. Drugs 60: 33-40
9. Beevi SS, Rasheed AM, Geetha A (2004). Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 34: 379-385
10. Carmichael J, DeGraffWG, Gazdar AF, Minna JD, Mitchell JB (1987a). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942
11. Carmichael J, DeGraffWG, Gazdar AF, Minna JD, Mitchell JB (1987b). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943-946
12. Chakravarti N, Myers JN, Aggarwal BB (2006). Targeting consecutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferyloymethane). Int J Cancer 119: 1268-1275
13. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM (2004). Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23: 1599-1607
14. Cheng AL, Hsu CH, Lin JK et al (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900
15. Cheng HC, Chein H, Liao CH, Yang YY, Huang SY (2007). Carotenoids suppress proliferating cell nuclear antigen and cyclin D1 expression in oral carcinogenic models. J Nutr Biochem 18: 667-675
16. Clark CA, McEachern MD, Shah SH et al (2010). Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rampamycin pathway activation in head and neck squamous cell carcinoma. Cancer Prev Res (Phila) 3: 1586-1595
17. Clinton SK (1998). Lycopene: chemistry, biology and implications for human health and disease. Nutr Rev 56: 35-51
18. Deryugina E, Quigley J (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34
19. Di Franco R, Calvanese M, Murino P et al (2012). Skin toxicity from external beam radiation therapy in breast cáncer patients: protective effects of Resveratrol, Lycopene, Vitamin C and anthocianin (Ixor®). Radiat Oncol 30:.12
20. Di Mascio P, Kaiser S, Sies H (1989). Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274: 532-538
21. Fazekas Z, Gao D, Saladi RN, Lu Y, Lebwohl M, Wei H (2003). Protective effects of lycopene against ultraviolet Binduced photodamage. Nutr Cancer 47: 181-187
22. Gerhartz M, Baranowsky A, Siebolts U et al (2007). Morphometric analysis of murine skin wound healing: standardization of experimental procedures and impact of an advanced multitissue array technique. Wound Repair Regen 15: 105-112
23. Gokul S, Patil V, Jailkhani R, Hallikeri K, Kattappagari K (2010). Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis 16: 29-33
24. Gupta PC, Hebert JR, Bhomsle RB, Sinor PN, Mehta H, Mehta FS (1998). Dietary factors in oral leukoplakia and submucous fibrosis in a population-based case control study in Gujarat, India. Oral Dis 4: 200-206
25. Heber D, Lu QY (2002). Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 227: 920-923
26. Jagetia GC (2007). Radioprotection and radiosensitization by curcumin. Adv Exp Med Biol 595: 301-320
27. Johnson JJ, Mukhtar H (2007). Curcumin for chemoprevention of colon cancer. Cancer Lett 255: 170-181
28. Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE (2005). Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132: 317-321
29. Khafif A, Lev-Ari S, Vexler A et al (2009). Curcumin: a potential radio-enhancer in head and neck cancer. Laryngoscope 119: 2019-2026
30. Kumar A, Bagewadi A, Keluskar V, Singh M (2007). Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103: 207-213
31. Kunjnumakkara A, Anand P, Aggarwal B (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225
32. Li L, Braiteh FS, Kurzrock R (2005). Liposome-encapsulated curcumin: in vitro and in vivo effect on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104: 1322-1331
33. Livny O, Kaplan I, Reifen R, Polak-Charcon S, Madar Z, Schwartz B (2002). Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J Nutr 132: 3754-3759
34. López-Jornet P, Camacho-Alonso F, Gómez-Garcia F (2011). Effect of curcumin and irradiation in PE/CA-PJ15 oral squamous cell carcinoma. Acta Odontol Scand 69: 269-273
35. LoTempio MM, Veena MS, Steele HL et al (2005). Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11: 6994-7002
36. Lu R, Dan H, Wu R et al (2011). Lycopene features and potential significance in the oral cancer and precancerous lesions. J Oral Pathol Med 40: 361-368
37. Mackerras D, Buffler PA, Randall DE, Nichaman MZ, Pickle LW, Mason TJ (1988). Carotene intake and the risk of laryngeal cancer in coastal Texas. Am J Epidemiol 128: 980-988
38. Mayne ST, Cartmel B, Lin H, Zheng T, Goodwin WJ Jr (2004). Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx or larynx cancers. J Am Coll Nutr 23: 34-42
39. Moreno-Jiménez M, Valero J, López-Picazo JM et al (2010). Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules. Am J Clin Oncol 33: 137-143
40. Nathan C, Amirghahari N, Rice C, Abreo F, Shi R, Stucker F (2002). Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 112: 2129-2140
41. Newman DJ, Cragg GM, Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037
42. O-charoenrat P, Rhys-Evans P, Eccles S (2001). Expression of matrix metaloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813-820
43. Oridate N, Kim HJ, Xu X, Lotan R (2005). Growth inhibition of heak and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin. Cancer Biol Ther 4: 318-323
44. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
45. Petersen PE (2009). Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol 45: 454-460
46. Pignon JP, Bourhis J, Domenge C, Designe L (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data MACH-NC Collaborative Group. MetaAnalysis of chemotherapy on head and neck cancer. Lancet 355: 949-955
47. Ramachandran C, Rodriguez S, Ramachandran R et al (2005). Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 25: 3293-3302
48. Reddy AC, Lokesh BR (1992). Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem 111: 117-124
49. Reid BC, Winn DM, Morse DE, Pendrys DG (2000). Head and neck in situ carcinoma: incidente, trends, and survival. Oral Oncol 36: 414-420
50. Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M (2008). Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76: 1340-1351
51. Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA (2005). Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 24: 47-69
52. Singh M, Krishanappa R, Bagewadi A, Keluskar V (2004). Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol 40: 591-596
53. Srinivasan M, Rajendra Prasad N, Menon VP (2006). Protective effect of curcumin on gama-radiation induced DNA damage and lipid peroxidation in cultured lymphocytes. Mutat Res 611: 96-103
54. Stahl W, Sies H (1996). Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 336: 1-9
55. Story EN, Kopec RE, Schwartz SJ, Harris GK (2010). An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 1: 189-210
56. Strimpakos AS, Sharma RA (2008). Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10: 511-545
57. Tabassum A, Bristow RG, Venkateswaran V (2010). Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing? Cancer Treat Rev 36: 230-234
58. Tavani A, Negri E, Franceschi S, Barbone F, La Vecchia C (1994). Attributable risk for laryngeal cancer in Northern Italy. Cancer Epidemiol Biomark Prev 3: 121-125
59. Ukai N, Lu Y, Etoh H (1994). Photosensitized oxygenation of lycopene. Biosci Biotechnol Biochem 58: 1718-1719
60. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M (2005). Cell migration and invasion assays. Methods 37: 208-215
61. Van Breemen RB, Pajkovic N (2008). Multitargeted therapy of cancer by lycopene. Cancer Lett 269: 339-351